Loading…
Postbiotic gel relieves clinical symptoms of bacterial vaginitis by regulating the vaginal microbiota
Vaginitis is the most common disease in gynecology. Vaginal dysbiosis is a main reason of bacteria vaginitis (BV), as the disrupted microecological environment facilitates the growth of various vaginal pathogens. The most dominant bacteria in the vaginal microbiota are lactic acid bacteria, which ar...
Saved in:
Published in: | Frontiers in cellular and infection microbiology 2023-02, Vol.13, p.1114364-1114364 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c468t-21a8f1ff55d7d03f42f039ebc0a01d48cd8e90d3a658b671185382bf0eecbc33 |
---|---|
cites | cdi_FETCH-LOGICAL-c468t-21a8f1ff55d7d03f42f039ebc0a01d48cd8e90d3a658b671185382bf0eecbc33 |
container_end_page | 1114364 |
container_issue | |
container_start_page | 1114364 |
container_title | Frontiers in cellular and infection microbiology |
container_volume | 13 |
creator | Shen, Xin Xu, Lin Zhang, Zhiquan Yang, Yitong Li, Pengxian Ma, Teng Guo, Shuai Kwok, Lai-Yu Sun, Zhihong |
description | Vaginitis is the most common disease in gynecology. Vaginal dysbiosis is a main reason of bacteria vaginitis (BV), as the disrupted microecological environment facilitates the growth of various vaginal pathogens. The most dominant bacteria in the vaginal microbiota are lactic acid bacteria, which are important for maintaining vaginal health. At present, antibiotics and other drugs are often used in clinical treatment, but there are many adverse reactions and easy to relapse, and the intervention of probiotics can help restore vaginal microbiota and alleviate BV. This study is a human clinical trial of 50 patients with bacterial vaginitis (BV). The alleviation effect of applying a postbiotic gel for one week in BV was evaluated. Changes in patients' clinical indicators of BV (properties of vaginal secretion) and the vaginal microbiota after using the postbiotic gel were monitored. Our results showed that apply the postbiotic gel improved the symptoms of BV, indicated by improvement in the abnormalities of patients' vaginal secretions. After applying the gel, the relative abundance of vaginal lactobacilli increased compared to baseline. Significant negative correlations were found between lactobacilli and potential vaginal pathogens (including
,
, and
), as well as the abnormalities of the vaginal secretion. Overall, our results showed that applying the postbiotic gel ameliorated BV, and the symptom improvement was accompanied by significant changes in the bacterial vaginal microbiota. Our study provides valuable clinical data in managing BV. |
doi_str_mv | 10.3389/fcimb.2023.1114364 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_2034575c4aa54ab59de44abbb82b8ed9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_2034575c4aa54ab59de44abbb82b8ed9</doaj_id><sourcerecordid>2779343460</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-21a8f1ff55d7d03f42f039ebc0a01d48cd8e90d3a658b671185382bf0eecbc33</originalsourceid><addsrcrecordid>eNpVkU1v3CAQhq2qUROl-QM5RD72sltgsA2XSlXUj0iR2kPuCPDgEGGzAXal_fdls9so4TJo3plnBt6muaZkDSDkV2f9bNaMMFhTSjn0_ENzwRh0KyaF-Pjmft5c5fxE6hkIExI-NefQC9p3Qlw0-DfmYnws3rYThjZh8LjD3NrgF291aPN-3pQ45za61mhbMPma3emp6sXn1uxr07QNuvhlassjHrVaM3ub4oGtPzdnToeMV6d42Tz8_PFw-3t1_-fX3e33-5XlvSgrRrVw1LmuG4eRgOPMEZBoLNGEjlzYUaAkI-i6u-kHSkUHghlHEK2xAJfN3RE7Rv2kNsnPOu1V1F69JGKalE71pQEVI8C7obNc645r08kReY3GVJ7AUVbWtyNrszUzjhaXknR4B32vLP5RTXGnpIQeKK2ALydAis9bzEXNPlsMQS8Yt1mxYZDAgfeklrJjaf2vnBO61zGUqIPb6sVtdXBbndyuTTdvF3xt-e8t_AMizqoV</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2779343460</pqid></control><display><type>article</type><title>Postbiotic gel relieves clinical symptoms of bacterial vaginitis by regulating the vaginal microbiota</title><source>PubMed Central</source><creator>Shen, Xin ; Xu, Lin ; Zhang, Zhiquan ; Yang, Yitong ; Li, Pengxian ; Ma, Teng ; Guo, Shuai ; Kwok, Lai-Yu ; Sun, Zhihong</creator><creatorcontrib>Shen, Xin ; Xu, Lin ; Zhang, Zhiquan ; Yang, Yitong ; Li, Pengxian ; Ma, Teng ; Guo, Shuai ; Kwok, Lai-Yu ; Sun, Zhihong</creatorcontrib><description>Vaginitis is the most common disease in gynecology. Vaginal dysbiosis is a main reason of bacteria vaginitis (BV), as the disrupted microecological environment facilitates the growth of various vaginal pathogens. The most dominant bacteria in the vaginal microbiota are lactic acid bacteria, which are important for maintaining vaginal health. At present, antibiotics and other drugs are often used in clinical treatment, but there are many adverse reactions and easy to relapse, and the intervention of probiotics can help restore vaginal microbiota and alleviate BV. This study is a human clinical trial of 50 patients with bacterial vaginitis (BV). The alleviation effect of applying a postbiotic gel for one week in BV was evaluated. Changes in patients' clinical indicators of BV (properties of vaginal secretion) and the vaginal microbiota after using the postbiotic gel were monitored. Our results showed that apply the postbiotic gel improved the symptoms of BV, indicated by improvement in the abnormalities of patients' vaginal secretions. After applying the gel, the relative abundance of vaginal lactobacilli increased compared to baseline. Significant negative correlations were found between lactobacilli and potential vaginal pathogens (including
,
, and
), as well as the abnormalities of the vaginal secretion. Overall, our results showed that applying the postbiotic gel ameliorated BV, and the symptom improvement was accompanied by significant changes in the bacterial vaginal microbiota. Our study provides valuable clinical data in managing BV.</description><identifier>ISSN: 2235-2988</identifier><identifier>EISSN: 2235-2988</identifier><identifier>DOI: 10.3389/fcimb.2023.1114364</identifier><identifier>PMID: 36816588</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Bacteria ; bacterial vaginitis ; Cellular and Infection Microbiology ; Female ; Gardnerella ; Humans ; lactobacilli ; Lactobacillus - physiology ; Microbiota ; postbiotic ; Vagina - microbiology ; vaginal microbiota ; Vaginosis, Bacterial - microbiology</subject><ispartof>Frontiers in cellular and infection microbiology, 2023-02, Vol.13, p.1114364-1114364</ispartof><rights>Copyright © 2023 Shen, Xu, Zhang, Yang, Li, Ma, Guo, Kwok and Sun.</rights><rights>Copyright © 2023 Shen, Xu, Zhang, Yang, Li, Ma, Guo, Kwok and Sun 2023 Shen, Xu, Zhang, Yang, Li, Ma, Guo, Kwok and Sun</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-21a8f1ff55d7d03f42f039ebc0a01d48cd8e90d3a658b671185382bf0eecbc33</citedby><cites>FETCH-LOGICAL-c468t-21a8f1ff55d7d03f42f039ebc0a01d48cd8e90d3a658b671185382bf0eecbc33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936311/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936311/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36816588$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shen, Xin</creatorcontrib><creatorcontrib>Xu, Lin</creatorcontrib><creatorcontrib>Zhang, Zhiquan</creatorcontrib><creatorcontrib>Yang, Yitong</creatorcontrib><creatorcontrib>Li, Pengxian</creatorcontrib><creatorcontrib>Ma, Teng</creatorcontrib><creatorcontrib>Guo, Shuai</creatorcontrib><creatorcontrib>Kwok, Lai-Yu</creatorcontrib><creatorcontrib>Sun, Zhihong</creatorcontrib><title>Postbiotic gel relieves clinical symptoms of bacterial vaginitis by regulating the vaginal microbiota</title><title>Frontiers in cellular and infection microbiology</title><addtitle>Front Cell Infect Microbiol</addtitle><description>Vaginitis is the most common disease in gynecology. Vaginal dysbiosis is a main reason of bacteria vaginitis (BV), as the disrupted microecological environment facilitates the growth of various vaginal pathogens. The most dominant bacteria in the vaginal microbiota are lactic acid bacteria, which are important for maintaining vaginal health. At present, antibiotics and other drugs are often used in clinical treatment, but there are many adverse reactions and easy to relapse, and the intervention of probiotics can help restore vaginal microbiota and alleviate BV. This study is a human clinical trial of 50 patients with bacterial vaginitis (BV). The alleviation effect of applying a postbiotic gel for one week in BV was evaluated. Changes in patients' clinical indicators of BV (properties of vaginal secretion) and the vaginal microbiota after using the postbiotic gel were monitored. Our results showed that apply the postbiotic gel improved the symptoms of BV, indicated by improvement in the abnormalities of patients' vaginal secretions. After applying the gel, the relative abundance of vaginal lactobacilli increased compared to baseline. Significant negative correlations were found between lactobacilli and potential vaginal pathogens (including
,
, and
), as well as the abnormalities of the vaginal secretion. Overall, our results showed that applying the postbiotic gel ameliorated BV, and the symptom improvement was accompanied by significant changes in the bacterial vaginal microbiota. Our study provides valuable clinical data in managing BV.</description><subject>Bacteria</subject><subject>bacterial vaginitis</subject><subject>Cellular and Infection Microbiology</subject><subject>Female</subject><subject>Gardnerella</subject><subject>Humans</subject><subject>lactobacilli</subject><subject>Lactobacillus - physiology</subject><subject>Microbiota</subject><subject>postbiotic</subject><subject>Vagina - microbiology</subject><subject>vaginal microbiota</subject><subject>Vaginosis, Bacterial - microbiology</subject><issn>2235-2988</issn><issn>2235-2988</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1v3CAQhq2qUROl-QM5RD72sltgsA2XSlXUj0iR2kPuCPDgEGGzAXal_fdls9so4TJo3plnBt6muaZkDSDkV2f9bNaMMFhTSjn0_ENzwRh0KyaF-Pjmft5c5fxE6hkIExI-NefQC9p3Qlw0-DfmYnws3rYThjZh8LjD3NrgF291aPN-3pQ45za61mhbMPma3emp6sXn1uxr07QNuvhlassjHrVaM3ub4oGtPzdnToeMV6d42Tz8_PFw-3t1_-fX3e33-5XlvSgrRrVw1LmuG4eRgOPMEZBoLNGEjlzYUaAkI-i6u-kHSkUHghlHEK2xAJfN3RE7Rv2kNsnPOu1V1F69JGKalE71pQEVI8C7obNc645r08kReY3GVJ7AUVbWtyNrszUzjhaXknR4B32vLP5RTXGnpIQeKK2ALydAis9bzEXNPlsMQS8Yt1mxYZDAgfeklrJjaf2vnBO61zGUqIPb6sVtdXBbndyuTTdvF3xt-e8t_AMizqoV</recordid><startdate>20230202</startdate><enddate>20230202</enddate><creator>Shen, Xin</creator><creator>Xu, Lin</creator><creator>Zhang, Zhiquan</creator><creator>Yang, Yitong</creator><creator>Li, Pengxian</creator><creator>Ma, Teng</creator><creator>Guo, Shuai</creator><creator>Kwok, Lai-Yu</creator><creator>Sun, Zhihong</creator><general>Frontiers Media S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230202</creationdate><title>Postbiotic gel relieves clinical symptoms of bacterial vaginitis by regulating the vaginal microbiota</title><author>Shen, Xin ; Xu, Lin ; Zhang, Zhiquan ; Yang, Yitong ; Li, Pengxian ; Ma, Teng ; Guo, Shuai ; Kwok, Lai-Yu ; Sun, Zhihong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-21a8f1ff55d7d03f42f039ebc0a01d48cd8e90d3a658b671185382bf0eecbc33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Bacteria</topic><topic>bacterial vaginitis</topic><topic>Cellular and Infection Microbiology</topic><topic>Female</topic><topic>Gardnerella</topic><topic>Humans</topic><topic>lactobacilli</topic><topic>Lactobacillus - physiology</topic><topic>Microbiota</topic><topic>postbiotic</topic><topic>Vagina - microbiology</topic><topic>vaginal microbiota</topic><topic>Vaginosis, Bacterial - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shen, Xin</creatorcontrib><creatorcontrib>Xu, Lin</creatorcontrib><creatorcontrib>Zhang, Zhiquan</creatorcontrib><creatorcontrib>Yang, Yitong</creatorcontrib><creatorcontrib>Li, Pengxian</creatorcontrib><creatorcontrib>Ma, Teng</creatorcontrib><creatorcontrib>Guo, Shuai</creatorcontrib><creatorcontrib>Kwok, Lai-Yu</creatorcontrib><creatorcontrib>Sun, Zhihong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in cellular and infection microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shen, Xin</au><au>Xu, Lin</au><au>Zhang, Zhiquan</au><au>Yang, Yitong</au><au>Li, Pengxian</au><au>Ma, Teng</au><au>Guo, Shuai</au><au>Kwok, Lai-Yu</au><au>Sun, Zhihong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Postbiotic gel relieves clinical symptoms of bacterial vaginitis by regulating the vaginal microbiota</atitle><jtitle>Frontiers in cellular and infection microbiology</jtitle><addtitle>Front Cell Infect Microbiol</addtitle><date>2023-02-02</date><risdate>2023</risdate><volume>13</volume><spage>1114364</spage><epage>1114364</epage><pages>1114364-1114364</pages><issn>2235-2988</issn><eissn>2235-2988</eissn><abstract>Vaginitis is the most common disease in gynecology. Vaginal dysbiosis is a main reason of bacteria vaginitis (BV), as the disrupted microecological environment facilitates the growth of various vaginal pathogens. The most dominant bacteria in the vaginal microbiota are lactic acid bacteria, which are important for maintaining vaginal health. At present, antibiotics and other drugs are often used in clinical treatment, but there are many adverse reactions and easy to relapse, and the intervention of probiotics can help restore vaginal microbiota and alleviate BV. This study is a human clinical trial of 50 patients with bacterial vaginitis (BV). The alleviation effect of applying a postbiotic gel for one week in BV was evaluated. Changes in patients' clinical indicators of BV (properties of vaginal secretion) and the vaginal microbiota after using the postbiotic gel were monitored. Our results showed that apply the postbiotic gel improved the symptoms of BV, indicated by improvement in the abnormalities of patients' vaginal secretions. After applying the gel, the relative abundance of vaginal lactobacilli increased compared to baseline. Significant negative correlations were found between lactobacilli and potential vaginal pathogens (including
,
, and
), as well as the abnormalities of the vaginal secretion. Overall, our results showed that applying the postbiotic gel ameliorated BV, and the symptom improvement was accompanied by significant changes in the bacterial vaginal microbiota. Our study provides valuable clinical data in managing BV.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>36816588</pmid><doi>10.3389/fcimb.2023.1114364</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2235-2988 |
ispartof | Frontiers in cellular and infection microbiology, 2023-02, Vol.13, p.1114364-1114364 |
issn | 2235-2988 2235-2988 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_2034575c4aa54ab59de44abbb82b8ed9 |
source | PubMed Central |
subjects | Bacteria bacterial vaginitis Cellular and Infection Microbiology Female Gardnerella Humans lactobacilli Lactobacillus - physiology Microbiota postbiotic Vagina - microbiology vaginal microbiota Vaginosis, Bacterial - microbiology |
title | Postbiotic gel relieves clinical symptoms of bacterial vaginitis by regulating the vaginal microbiota |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T21%3A13%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Postbiotic%20gel%20relieves%20clinical%20symptoms%20of%20bacterial%20vaginitis%20by%20regulating%20the%20vaginal%20microbiota&rft.jtitle=Frontiers%20in%20cellular%20and%20infection%20microbiology&rft.au=Shen,%20Xin&rft.date=2023-02-02&rft.volume=13&rft.spage=1114364&rft.epage=1114364&rft.pages=1114364-1114364&rft.issn=2235-2988&rft.eissn=2235-2988&rft_id=info:doi/10.3389/fcimb.2023.1114364&rft_dat=%3Cproquest_doaj_%3E2779343460%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c468t-21a8f1ff55d7d03f42f039ebc0a01d48cd8e90d3a658b671185382bf0eecbc33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2779343460&rft_id=info:pmid/36816588&rfr_iscdi=true |